KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Raw Materials (2016 - 2018)

Teva Pharmaceutical Industries filings provide 9 years of Raw Materials readings, the most recent being $1.3 billion for Q4 2018.

  • On a quarterly basis, Raw Materials fell 8.67% to $1.3 billion in Q4 2018 year-over-year; TTM through Dec 2018 was $1.3 billion, a 8.67% decrease, with the full-year FY2018 number at $1.3 billion, down 8.67% from a year prior.
  • Raw Materials hit $1.3 billion in Q4 2018 for Teva Pharmaceutical Industries, down from $1.4 billion in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.5 billion in Q1 2018 to a low of $1.2 billion in Q4 2015.
  • Median Raw Materials over the past 5 years was $1.4 billion (2016), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Raw Materials: decreased 18.85% in 2014 and later increased 15.9% in 2016.
  • Teva Pharmaceutical Industries' Raw Materials stood at $1.3 billion in 2014, then dropped by 6.57% to $1.2 billion in 2015, then increased by 15.9% to $1.4 billion in 2016, then rose by 4.98% to $1.5 billion in 2017, then fell by 8.67% to $1.3 billion in 2018.
  • The last three reported values for Raw Materials were $1.3 billion (Q4 2018), $1.4 billion (Q3 2018), and $1.4 billion (Q2 2018) per Business Quant data.